Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 117
Infectious Diseases Drugs 88
Endocrine and Metabolic Disorders Drugs 75
Central Nervous System Drugs 59
Genomics 59
Immune Disorders Drugs 57
Pharmaceuticals 45
Drug Discovery 41
Diabetes Drugs 41
Prostate Cancer Drugs 41
Vaccines 40
Biopharmaceuticals 37
Urological Disorders Drugs 35
Clinical Trials 33
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 30
Biotechnology 28
Cardiovascular Drugs 26
Musculoskeletal Disorders Drugs 26
Leukemia Drugs 25
Liver and Kidney Disorders Drugs 25
Immunosuppressive Drugs 23
Antibiotics 22
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Stem Cells 19
Surgical Procedures 19
Oncology 18
Analgesics 17
Optical 14
Urology and Nephrology 13
Lung Cancer Drugs 13
Medical Devices 13
Infusions and Injectables 12
Diagnostics 12
Drug Delivery 12
Bladder Cancer Drugs 11
Dermatology 11
Healthcare Services 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Respiratory Drugs 8
Pharmaceutical Manufacturing 8
Pulmonary Medicine 7
Neurology 7
Lymphoma Drugs 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Biomaterials 6
Hearing Aids and Implants 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Needles and Syringes 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Pediatrics 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Skin Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Palliative Care 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anatomy 1
Endocrinology 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

1,131 Results (Page 31 of 57)
- Relevance
  Sort by

Hospital Acquired Infection Treatment - Global Strategic Business Report 2026

 Report
November 2026
231 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Cryptococcosis Treatment - Global Strategic Business Report

 Report
November 2026
193 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Antifungal Treatment - Global Strategic Business Report

 Report
November 2026
590 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Candidiasis Therapeutics - Global Strategic Business Report

 Report
November 2026
474 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Aspergillosis Drugs - Global Strategic Business Report

 Report
November 2026
373 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Candidiasis Drugs - Global Strategic Business Report

 Report
November 2026
250 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Cancer Biologics Market Report 2023-2033

 Report
June 2023
308 Pages
Global

From

€4901EUR$5,467USD£3,950GBP

Oral Proteins & Peptides Market - Global Forecast 2026-2032

 Report
September 2026
193 Pages
Global

From

€3289EUR$3,545USD£2,744GBP

€3655EUR$3,939USD£3,049GBP

Licensing Deals in Biotechnology 2021-2026

 Report
September 2026
1000 Pages
Global

From

€4635EUR$4,995USD£3,866GBP

Oropharyngeal Candidiasis - Global Strategic Business Report

 Report
November 2026
462 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Neglected Tropical Disease Treatment - Global Strategic Business Report

 Report
November 2026
294 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Aspergillosis Treatment - Global Strategic Business Report

 Report
November 2026
374 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Cryptococcosis Therapeutics - Global Strategic Business Report

 Report
November 2026
473 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Viral Hepatitis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4166EUR$4,490USD£3,475GBP

In Silico Clinical Trials Market Report 2023-2033

 Report
September 2023
231 Pages
Global

From

€4901EUR$5,467USD£3,950GBP

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
321 Pages
Global

€4635EUR$4,995USD£3,866GBP

Regenerative Medicine Market Report 2023-2033

 Report
March 2023
232 Pages
Global

From

€4901EUR$5,467USD£3,950GBP

Pharmerging - Global Strategic Business Report 2026

 Report
November 2026
198 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Regenerative Medicine Market Size, Share & Trends Analysis Report by Product (Therapeutics, Tools, Banks), Therapeutic Category (Dermatology, Musculoskeletal, Immunology & Inflammation), and Region with Growth Forecasts, 2025-2030

 Report
May 2025
245 Pages
Global

From

€5521EUR$5,950USD£4,605GBP

Motion Sickness Treatment Market - Global Forecast 2026-2032

 Report
September 2026
185 Pages
Global

From

€3289EUR$3,545USD£2,744GBP

€3655EUR$3,939USD£3,049GBP

1,131 Results (Page 31 of 57)
- 1
- 29
- 30
- 31
- 32
- 33

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.